Filing Details

Accession Number:
0000059478-14-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-04 15:48:12
Reporting Period:
2014-02-03
Filing Date:
2014-02-04
Accepted Time:
2014-02-04 15:48:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1359067 W Derica Rice Lilly Corporate Center
Indianapolis IN 46285
Evp-Global Services And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-03 16,562 $0.00 58,990 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,762 Indirect 401(k)
Common Stock 217,524 Indirect by wife
Common Stock 1,758 Indirect 401(k) - by wife
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2013.
  2. This transaction was executed in multiple trades at prices ranging from $53.46 to $53.75. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Reporting person disclaims beneficial ownership of these shares.